Gold Mining News – Lifestyle
Home
Sample Page
Author:
Design Therapeutics, Inc.
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
April 28, 2026
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
March 9, 2026